Methotrexate-associated lymphoproliferative disorders
Methotrexate-associated lymphoproliferative disorders
Definition
Methotrexate-associated lymphoproliferative disorders are rare immunodeficiency-associated lymphoproliferative diseases characterized by lymphoid proliferation or lymphomas (large B-cell lymphoma, T-cell lymphoma, Hodgkin lymphoma, reactive lymphadenitis and a polymorphic post-transplant lymphoproliferative disorder) that develop in patients with different autoimmune diseases treated with methotrexate. Swelling is the predominant manifestation of the disease and regression after methotrexate withdrawal is observed in a significant proportion of patients.
Also known as methotrexate-associated lymphoproliferation, methotrexate-associated lymphoproliferative disorder, MTX-associated lymphoproliferative disorders, MTX-LPD — per MONDO
Also identified as
Affected Organs
| Organ | Involvement | Source |
|---|---|---|
| Lymphoid system | Disease Has Primary Anatomic Site | NCIT · CC BY 4.0 |